Search Results - "Pietruck, F"

Refine Results
  1. 1
  2. 2

    Pharmacokinetics for Once‐ Versus Twice‐Daily Tacrolimus Formulations in De Novo Kidney Transplantation: A Randomized, Open‐Label Trial by Wlodarczyk, Z., Squifflet, J.‐P., Ostrowski, M., Rigotti, P., Stefoni, S., Citterio, F., Vanrenterghem, Y., Krämer, B. K., Abramowicz, D., Oppenheimer, F., Pietruck, F., Russ, G., Karpf, C., Undre, N.

    Published in American journal of transplantation (01-11-2009)
    “…Tacrolimus, a cornerstone immunosuppressant, is widely available as a twice‐daily formulation (Tacrolimus BID). A once‐daily prolonged‐release formulation…”
    Get full text
    Journal Article Web Resource
  3. 3

    Sotrastaurin, a Novel Small Molecule Inhibiting Protein Kinase C: First Clinical Results in Renal‐Transplant Recipients by Budde, K., Sommerer, C., Becker, T., Asderakis, A., Pietruck, F., Grinyo, J. M., Rigotti, P., Dantal, J., Ng, J., Barten, M. J., Weber, M.

    Published in American journal of transplantation (01-03-2010)
    “…Sotrastaurin, a novel protein‐kinase‐C inhibitor, blocks early T‐cell activation. In this 12‐month, Phase II study, de novo renal‐transplant patients were…”
    Get full text
    Journal Article
  4. 4

    Repaglinide in the Management of New‐Onset Diabetes Mellitus After Renal Transplantation by Türk, T., Pietruck, F., Dolff, S., Kribben, A., Janssen, O. E., Mann, K., Philipp, T., Heemann, U., Witzke, O.

    Published in American journal of transplantation (01-04-2006)
    “…The purpose of this study was to investigate the use of the short‐acting insulin secretion drug repaglinide in new‐onset diabetes mellitus (NODM) after renal…”
    Get full text
    Journal Article
  5. 5

    Ezetimibe for the Treatment of Uncontrolled Hypercholesterolemia in Patients with High‐Dose Statin Therapy After Renal Transplantation by Kohnle, M., Pietruck, F., Kribben, A., Philipp, Th, Heemann, U., Witzke, O.

    Published in American journal of transplantation (01-01-2006)
    “…We investigated prospectively the efficacy of ezetimibe in addition to statin therapy in stable renal transplant patients in whom hypercholesterolemia was not…”
    Get full text
    Journal Article
  6. 6

    Serum cystatin C--a superior marker of rapidly reduced glomerular filtration after uninephrectomy in kidney donors compared to creatinine by Herget-Rosenthal, S, Pietruck, F, Volbracht, L, Philipp, T, Kribben, A

    Published in Clinical nephrology (01-07-2005)
    “…Acute renal failure (ARF), defined by a rapid decrease of glomerular filtration rate (GFR), is associated with high mortality. Early and accurate detection of…”
    Get more information
    Journal Article
  7. 7

    Nephrotoxicity of iso-osmolar versus low-osmolar contrast media is equal in low risk patients by Feldkamp, T, Baumgart, D, Elsner, M, Herget-Rosenthal, S, Pietruck, F, Erbel, R, Philipp, T, Kribben, A

    Published in Clinical nephrology (01-11-2006)
    “…Contrast media-induced nephropathy (CIN) is an increasing cause of hospital-acquired acute kidney injury and leads to a significant increase in mortality…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Relationship of Hepatitis B or C Virus Prevalences, Risk Factors, and Outcomes in Renal Transplant Recipients: Analysis of German Data by Kliem, V, Burg, M, Haller, H, Suwelack, B, Abendroth, D, Fritsche, L, Fornara, P, Pietruck, F, Frei, U, Donauer, J, Lison, A.E, Michel, U

    Published in Transplantation proceedings (01-05-2008)
    “…Abstract Background Chronic liver disease resulting from hepatitis B (HBV) and hepatitis C (HCV) virus infections is still a major concern in kidney…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Organic cation transport in the rat kidney in vivo visualized by time-resolved two-photon microscopy by Hörbelt, M., Wotzlaw, C., Sutton, T.A., Molitoris, B.A., Philipp, T., Kribben, A., Fandrey, J., Pietruck, F.

    Published in Kidney international (01-08-2007)
    “…Secretion of cationic drugs and endogenous metabolites is a major function of the kidney accomplished by tubular organic cation transport systems. A cationic…”
    Get full text
    Journal Article
  11. 11

    Conversion From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Stable Maintenance Renal Transplant Patients: Pooled Results From Three International, Multicenter Studies by Pietruck, F, Abbud-Filho, M, Vathsala, A, Massari, P.U, Po-Huang, L, Nashan, B

    Published in Transplantation proceedings (2007)
    “…Abstract Background Mycophenolate mofetil (MMF) is effective in renal transplant patients but concerns remain over its gastrointestinal (GI) tolerability…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Enhanced G protein activation in IDDM patients with diabetic nephropathy by PIETRUCK, F, SPLEITER, S, DAUL, A, PHILIPP, T, DERWAHL, M, SCHATZ, H, SIFFERT, W

    Published in Diabetologia (01-01-1998)
    “…Genetic susceptibility contributes significantly to the risk of developing nephropathy in insulin-dependent diabetes mellitus (IDDM). The cellular substrate…”
    Get full text
    Journal Article
  15. 15

    Cyclosporine-Based Immunosuppressive Strategies for Kidney Recipients: Interim Analysis of German Data From the Multinational Observational Study (MOST) by Kliem, V., Fritsche, L., Haller, H., Suwelack, B., Abendroth, D., Fornara, P., Pietruck, F., Frei, U., Donauer, J., Lison, A.E., Michel, U., Ulbricht, B.

    Published in Transplantation proceedings (01-04-2005)
    “…We collected data from kidney recipients with a functioning graft at German kidney transplant centers in order to analyze the efficacy of various cyclosporine…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Transport interactions of different organic cations during their excretion by the intact rat kidney by Pietruck, Frank, Ullrich, Karl J.

    Published in Kidney international (01-06-1995)
    “…Transport interactions of different organic cations during their excretion by the intact rat kidney. Organic cations, in addition to being filtrated, are…”
    Get full text
    Journal Article
  17. 17

    Two by two hour creatinine clearance--repeatable and valid by Herget-Rosenthal, S, Kribben, A, Pietruck, F, Ross, B, Philipp, T

    Published in Clinical nephrology (01-06-1999)
    “…The purpose of this study was to determine the repeatability and validity of 2 x 2 hour creatinine clearance, and the validity of creatinine clearances…”
    Get more information
    Journal Article
  18. 18

    Early detection of acute renal failure by serum cystatin C by Herget-rosenTHAL, Stefan, Marggraf, Günter, Hüsing, Johannes, Göring, Frauke, Pietruck, Frank, Janssen, Onno, Philipp, Thomas, Kribben, Andreas

    Published in Kidney international (01-09-2004)
    “…Early detection of acute renal failure by serum cystatin C. Acute renal failure (ARF) is associated with high mortality. Presently, no specific therapy for ARF…”
    Get full text
    Journal Article
  19. 19

    Prognostic Value of Tubular Proteinuria and Enzymuria in Nonoliguric Acute Tubular Necrosis by Herget-Rosenthal, Stefan, Poppen, Dennis, Husing, Johannes, Marggraf, Gunter, Pietruck, Frank, Jakob, Heinz-Gunther, Philipp, Thomas, Kribben, Andreas

    Published in Clinical chemistry (Baltimore, Md.) (01-03-2004)
    “…Acute tubular necrosis (ATN) has high mortality, especially in patients who require renal replacement therapy (RRT). We prospectively studied the diagnostic…”
    Get full text
    Journal Article
  20. 20